Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Poster Session

Immunobiology

Poster Session C
General Topic: Basic Science

(1770–1779) Cytokines & Cell Trafficking Poster

Tuesday, October 28, 2025
10:30 AM - 12:30 PM Central Time
Location: Hall F1
CE: 0.00

    Presentations:

    • 10:30 AM - 12:30 PM Central Time
      Citrullinated and Malondialdehyde-Acetaldehyde Modified Fibrinogen Activates Macrophages and Induces Inflammatory Responses in Coronary Endothelium

      Abstract Poster Presenter: Wenxian Zhou, BS – University of Nebraska Medical Center

    • 10:30 AM - 12:30 PM Central Time
      Interferon- α, Anti-Interferon-Alpha Antibodies and Disease Activity in Systemic Lupus Erythematosus

      Abstract Poster Presenter: Gollakota Nandita, MBBS/MD – NIMS, Hyderabad

    • 10:30 AM - 12:30 PM Central Time
      Towards an Earlier and Accurate Diagnosis of Connective Tissue Disease-related Interstitial Lung Disease: TGFB Isoform Genes as Upcoming Biomarkers

      Abstract Poster Presenter: Verónica Pulito Cueto, PhD – IDIVAL

    • 10:30 AM - 12:30 PM Central Time
      Correlation between Soluble Checkpoint Molecules and Disease Activity in Autoimmune Diseases

      Abstract Poster Presenter: Kosaku Murakami, MD, PhD (he/him/his) – Kyoto University

    • 10:30 AM - 12:30 PM Central Time
      Citrullinated and Malondialdehyde-Acetaldehyde Co-Modified Fibrinogen Activates Macrophages and Induces Pro-Fibrotic shift in Coronary Endothelium Phenotype

      Abstract Poster Presenter: Nozima Aripova, PhD – University of Nebraska Medical Center

    • 10:30 AM - 12:30 PM Central Time
      Redefining disease activity assessment in IgG4-Related Disease: The role of classical and novel biomarkers

      Abstract Poster Presenter: Marta López, MD – Complex Hospitalari Universitari Moisès Broggi

    • 10:30 AM - 12:30 PM Central Time
      Brepocitinib Inhibits Key Pathogenic Cytokine Signaling in Dermatomyositis Patients

      Abstract Poster Presenter: Christina Charles-Schoeman, MD;MS – UCLA Medical Center

    • 10:30 AM - 12:30 PM Central Time
      Granzyme B as a regulator of interferon alpha production in cutaneous lupus erythematosus

      Abstract Poster Presenter: Touraj Khosravi, MD, FRCPC, FAAD – University of British Columbia

    • 10:30 AM - 12:30 PM Central Time
      Preclinical Development of a Novel TL1A-Targeting Antibody with Extended Half-life and Low Immunogenicity Risk for the Treatment of Inflammatory Diseases

      Abstract Poster Presenter: Quan Yu, PhD – Ailux

    • 10:30 AM - 12:30 PM Central Time
      Study Of Type -1 Interferon Gene Signature Markers In Muscle Biopsy Samples Of Patients With IIM

      Abstract Poster Presenter: pradeep sosigowda, MBBS/MD/DM – NIMS